28819-05-8

Basic information

• Product Name: Z-ALA-OME
• Synonyms: N-[(Phenylmethoxy)carbonyl]-L-alanine methyl ester;N-Cbz-L-alanine methyl ester;N-carbobenzyloxy-L-alanine methyl ester;L-Alanine,N-[(phenylmethoxy)carbonyl]-, methyl ester;Z-L-Ala-OMe;N-ALPHA-CARBOBENZOXY-L-ALANINE METHYL ESTER;Z-ALA-OME;Z-L-ALANINE METHYL ESTER
• CAS NO: 28819-05-8
• Molecular Formula: C₁₂H₁₅NO₄
• Molecular Weight: 237.25
• EINECS: 1533716-785-6
• Mol File: 28819-05-8.mol
• Article Data: 74

Chemical Properties

• Melting Point: 46-47℃
• Boiling Point: 101.5 °C at 760 mmHg
• Appearance: /
• Density: 1.01 g/cm³
• Storage Temp.: 2-8°C
• PKA: 11.00±0.46(Predicted)
• CAS DataBase Reference: Z-ALA-OME(CAS DataBase Reference)
• NIST Chemistry Reference: Z-ALA-OME(28819-05-8)
• EPA Substance Registry System: Z-ALA-OME(28819-05-8)

Safety Data

• Hazardous Substances Data: 28819-05-8(Hazardous Substances Data)

Usage

General Description

Z-ALA-OME is a synthetic derivative of the amino acid alanine, which has been modified to improve its stability and function as a skin-care ingredient. It falls under the category of skincare peptide and is known for its potential anti-aging and antioxidant properties. Z-ALA-OME is believed to help protect the skin from oxidative damage, improve skin firmness, and promote collagen production. It is often used in cosmetic products such as serums, creams, and lotions to provide anti-aging and protective benefits to the skin. Overall, Z-ALA-OME is a promising ingredient in the skincare industry, with potential benefits for maintaining healthy and youthful-looking skin.

Upstream product

• 1142-20-7 N-Cbz-Ala 
• 79-22-1 methyl chloroformate 
• 2491-20-5 L-alanine methyl ester hydrochloride 
• 501-53-1 benzyl chloroformate 
• 67-56-1 methanol 
• 56-41-7 L-alanin 
• 186581-53-3 diazomethane 
• 26607-51-2 N-benzyloxycarbonyl-D-alanine 
• 4132-86-9 N-benzyloxycarbonylalanine 
• 21149-17-7 methyl 2-(benzyloxycarbonylamino)acrylate 
• 77-78-1 dimethyl sulfate 
• 10065-72-2 L-Alanine methyl ester 
• 24424-99-5 di-tert-butyl dicarbonate 
• 100-51-6 benzyl alcohol 

Downstream Products

• 6429-44-3 (S)-(-)-N-(benzyloxycarbonyl)alaninol 
• 127041-69-4 benzyl (2S,3R)-3-hydroxyhex-5-en-2-ylcarbamate 
• 127041-68-3 ((1S,2S)-2-Hydroxy-1-methyl-pent-4-enyl)-carbamic acid benzyl ester 
• 1142-20-7 N-Cbz-Ala 
• 13139-27-0 L-α-N-Cbz-alaninamide 
• 82353-55-7 benzyl (S)-1-oxopropan-2-ylcarbamate 
• 160056-97-3 (S)-Nα-(benzyloxycarbonyl)alanine hydroxamic acid 
• 160056-98-4 N-(Carbobenzyloxy)-D-alanine N-hydroxyamide 
• 18323-56-3 Z-(S)-Ala-(S)-Leu-NH₂ 
• 17350-66-2 N-benzyloxycarbonylalaninehydrazid 
• 159141-65-8 (2S,3S)-1-chloro-3-(benzyloxycarbonylamino)-2-butanol 
• 114744-90-0 ((S)-2-Hydroxy-1-methyl-butyl)-carbamic acid benzyl ester 
• 127041-68-3 (2S,3SR)-2-{[(benzyloxy)carbonyl]amino}hex-5-en-3-ol 
• 104863-92-5 ((S)-2-Hydroxy-1-methyl-2-phenyl-ethyl)-carbamic acid benzyl ester 

Relevant articles and documents

Sparsomycin analogs. II. Synthesis and biological activities of 5-carboxy-6-methyluracil derivatives

In order to study the structure-activity relationship of sparsomycin, an antitumor antibiotic, 26 sparsomycin-related compounds were synthesized and their antibacterial activities and lytic actions on Ehrlich ascites carcinoma cells were tested.

Substituted macrocyclic tyrosine kinase inhibitor and application thereof

The invention belongs to the technical field of medicines, and particularly relates to a substituted macrocyclic tyrosine kinase inhibitor compound, and pharmaceutically acceptable salts and stereoisomers thereof. More specifically, the tyrosine kinase is

Preparation method of carboxylic ester compound

The invention relates to a preparation method of a carboxylic ester compound, which comprises the following steps: reacting carboxylic acid with methanol in air under the catalysis of nitrite to obtain an ester compound, the preparation method disclosed by the invention has the advantages of rich raw material sources, cheap and easily available catalyst, mild reaction conditions, simplicity and convenience in operation and the like, a series of fatty carboxylic acids can be modified with high yield, and particularly, the traditional esterification method is generally not suitable for esterification of drug molecules. By utilizing the method, a series of known drug molecules can be modified, so that a shortcut is provided for discovering new drug molecules.